Current Drug Targets | BenthamScience

Aims & Scope

Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes.

Current Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts for publication mini- & full-length review articles and drug clinical trial studies.

As the discovery, identification, characterization and validation of novel human drug targets for drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

"In view of the growing volume of literature, the role of high quality review journals has become increasingly important. Current Drug Targets is an important journal in the field of medicinal chemistry and drug design, which is strongly recommended to the scientific community."

Jean-Marie Lehn
Nobel Laureate

Related Journals

Anti-Cancer Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of anti-cancer agents.

The journal Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry publishes expert reviews, original research articles, drug clinical trial studies and special topic issues.

Current Computer-Aided Drug Design aims to publish all the latest developments in drug design based on computational techniques. The field of computer-aided drug design has had extensive impact in the area of drug design.

Combinatorial Chemistry & High Throughput Screening is a high impact factor journal, having an impact factor 1.041, and is indexed by all major indexing agencies.

Current Cancer Therapy Reviews publishes frontier reviews, original research articles, drug clinical trial studies and guest edited thematic issues on all the latest advances in clinical oncology, cancer therapy and pharmacology. The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in cancer therapy.

The journal Current Drug Safety publishes frontier articles on all the latest advances on drug safety.

The journal Current Clinical Pharmacology publishes frontier reviews on all the latest advances in clinical pharmacology.

Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments in this field.

Current Drug Delivery journal is essential reading for all pharmaceutical scientists involved in drug design, development and delivery.

Current Organic Chemistry is a high impact factor journal, having an impact factor 1.949, and is indexed by all major indexing agencies.

Cardiovascular & Hematological Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new Cardiovascular & Hematological Agents.

Cardiovascular & Hematological Disorders-Drug is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Current Molecular Medicine is a high impact factor journal, having an impact factor 3.621 and is indexed by all major indexing agencies.

Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design.

Current Neuropharmacology is an impact factor journal and covers all areas of neuropharmacology and related matters of neuroscience.

Current Nanoscience is a high impact factor journal and is essential reading to all involved in nanoscience and its applied areas.

Current Gene Therapy is a bi-monthly peer-reviewed journal, aimed at academic and industrial scientists, with an interest in major topics concerning basic research and clinical applications of gene and cell therapy of genetic diseases.

Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

The Current Neurovascular Research emphasizes the elucidation of disease mechanisms, both cellular and molecular, which can impact the development of unique therapeutic strategies for neuronal and vascular disorders.

Current Pharmaceutical Analysis provides convincing and state-of-the-art reviews and original research articles to Pharmaceutical and Biomedical scientists.

Central Nervous System Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new central nervous system agents.

Current Topics in Medicinal Chemistry is essential reading for every medicinal chemist who wishes to be kept informed with the latest developments in medicinal chemistry and in other allied disciplines.

Current Vascular Pharmacology is a high impact factor journal, having an impact factor 2.374, and is indexed by all major indexing agencies.

Current Protein & Peptide Science is a high impact factor journal and is indexed by all major indexing agencies.

Recent Patents on Anti-Cancer Drug Discovery is essential reading for all researchers involved in anti-cancer drug design and discovery.

The journal Recent Patents on Anti-Infective Drug Discovery is essential reading for all researchers involved in anti-infective drug design and discovery.

Medicinal Chemistry is a peer-reviewed journal and aims to cover all the latest outstanding developments in medicinal chemistry and rational drug design.

Protein and Peptide Letters provides an excellent venue for communication of succinct reports of interesting research findings.

The journal Infectious Disorders - Drug Targets is essential reading for all pharmaceutical scientists involved in drug design, discovery and development.

Mini-Reviews in Medicinal Chemistry publishes short reviews on the important recent developments in medicinal chemistry and allied disciplines.

Letters in Drug Design & Discovery is essential reading for all pharmaceutical scientists involved in drug design and discovery.

The journal Endocrine, Metabolic & Immune Disorders-Drug Targets publishes timely reviews of experimental and clinical studies in the field of endocrine, metabolic, and immune disorders.

Current Stem Cell Research & Therapy is a high impact factor journal, and is essential reading for all researchers & clinicians involved in stem cells research.

The journal Recent Patents on CNS Drug Discovery is essential reading for all researchers involved in CNS drug design and discovery.

The journal Reviews on Recent Clinical Trials publishes frontier reviews, original research articles, drug clinical trial studies and guest edited thematic issues on recent clinical trials of major importance.

Current Alzheimer Research publishes peer-reviewed reviews, research, drug clinical trial studies and letter articles on all areas of Alzheimer’s disease.

Current HIV Research is a high impact factor journal and is essential reading for all the stakeholders involved in HIV research.

The journal Current Drug Discovery Technologies publishes comprehensive overviews of all the major modern techniques and technologies used in drug design and discovery.

CNS & Neurological Disorders - Drug Targets is a high impact factor journal and is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Current Proteomics publishes well-timed review articles on topics relevant and significant to the development of proteomics.

The journal Drug Metabolism Letters is widely read journal in its field, and is indexed by all the major indexing agencies. This journal is essential reading for all the researchers involved in drug metabolism and disposition studies

The journal Recent Patents on Drug Delivery & Formulation is essential reading for all researchers involved in the fields of drug delivery and formulation

The journal Recent Patents on Endocrine, Metabolic & Immune Drug Discovery is essential reading for all researchers involved in endocrine, metabolic and immune drug design and discovery

The journal Recent Patents on Inflammation & Allergy Drug Discovery is essential reading for all researchers involved in inflammation and allergy drug design and discovery.

Current Drug Target -Infectious Disorders

The journal Current Drug Abuse is of interest to a broad audience in its field, and is indexed by all the major indexing agencies

The journal Current Radiopharmaceuticals is essential reading for all the researchers involved in this field, and this journal is indexed by all the major indexing agencies

The journal publishes expert reviews, original research articles and thematic issues on molecular pharmacology

The journal Current Aging Science is essential reading for researchers, educators and physicians with interest in aging, age-related dementia and Alzheimer’s disease and longevity.

The journal Pharmaceutical Nanotechnology is essential reading for all the researchers involved in pharmaceutical implications of the nanotechnology.

Related E-Books

Bentham ebook::Biopolymers in Drug Delivery: Recent Advances and Challenges

Bentham ebook::Current Advances in Drug Delivery Through Fast Dissolving/Disintegrating Dosage Forms

Bentham ebook::Current Technologies to Increase the Transdermal Delivery of Drugs

Bentham ebook::Physical Penetration Enhancers: Therapeutic Applications and Devices

Bentham Science: About Us

Bentham Science is a science, technology, and medical (STM) publisher, providing academic researchers and industrial professionals with the latest information in diverse fields of science and technology. Our peer-reviewed scholarly journals and books have an ever-increasing readership of millions of researchers worldwide.

Bentham Science currently publishes more than 100 journals in both electronic and printed formats. Our journals cover various disciplines in pharmaceutical research and development, medical subspecialties, engineering, technology, and social sciences. The journals are indexed in recognized indexing agencies, such as Journal Citation Reports/Science Edition, MEDLINE/Index Medicus, PubMed, Scopus, Chemical Abstracts, EMBASE. ... Read More

Welcome To
Current Drug Targets

About the Journal

Aims & Scope

Ranking and Category

Targeting DNA Double-Strand Break (DSB) Repair to Counteract Tumor Radio-resistance

Age-related Macular Degeneration: Current Knowledge of Zinc Metalloproteinases Involvement

Potential Therapeutic Applications of P2 Receptor Antagonists: From Bench to Clinical Trials

Trans-sialidase Associated with Atherosclerosis: Defining the Identity of a Key Enzyme Involved in the Pathology

Saccharomyces cerevisiae (Baker’s Yeast) as an Interfering RNA Expression and Delivery System

The Plasminogen Activation System Promotes Neurorepair in the Ischemic Brain

Developing Practical Therapeutic Strategies that Target Protein SUMOylation

The Urokinase Plasminogen Activation System in Rheumatoid Arthritis: Pathophysiological Roles and Prospective Therapeutic Targets

Current Understanding of Group A Streptococcal Biofilms

Endorsement(s)

Announcements

Related Journals

Related E-Books

About the Publisher

Bentham Science: About Us

Indexed in

Welcome To Current Drug Targets

About the Journal

Aims & Scope

Ranking and Category

Targeting DNA Double-Strand Break (DSB) Repair to Counteract Tumor Radio-resistance

Age-related Macular Degeneration: Current Knowledge of Zinc Metalloproteinases Involvement

Potential Therapeutic Applications of P2 Receptor Antagonists: From Bench to Clinical Trials

Trans-sialidase Associated with Atherosclerosis: Defining the Identity of a Key Enzyme Involved in the Pathology

Saccharomyces cerevisiae (Baker’s Yeast) as an Interfering RNA Expression and Delivery System

The Plasminogen Activation System Promotes Neurorepair in the Ischemic Brain

Developing Practical Therapeutic Strategies that Target Protein SUMOylation

The Urokinase Plasminogen Activation System in Rheumatoid Arthritis: Pathophysiological Roles and Prospective Therapeutic Targets

Current Understanding of Group A Streptococcal Biofilms

Endorsement(s)

Announcements

Related Journals

Related E-Books

About the Publisher

Bentham Science: About Us

Indexed in

Welcome To
Current Drug Targets